These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35812632)

  • 1. Visceral Leishmaniasis (Kala-Azar): A Triumph Against a Trickster Disease.
    Pasha F; Saleem S; Nazir T; Tariq J; Qureshi K
    Cureus; 2022 Jun; 14(6):e25698. PubMed ID: 35812632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Leishmaniasis with cutaneous and visceral involvement in a 13-month old boy].
    Landmann E; Bogdan C; Donhauser N; Artlich A; Staude B; Gortner L
    Klin Padiatr; 2000; 212(5):266-7. PubMed ID: 11048286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congenital transmission of visceral leishmaniasis (Kala Azar) from an asymptomatic mother to her child.
    Meinecke CK; Schottelius J; Oskam L; Fleischer B
    Pediatrics; 1999 Nov; 104(5):e65. PubMed ID: 10545591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome wide comparison of Leishmania donovani strains from Indian visceral leishmaniasis and para-kala-azar dermal leishmaniasis patients.
    Sarraf NR; Mukhopadhyay S; Banerjee A; Das AK; Roy S; Chakrabarti S; Manna M; Saha P
    Acta Trop; 2021 Nov; 223():106086. PubMed ID: 34389331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xenodiagnosis to evaluate the infectiousness of humans to sandflies in an area endemic for visceral leishmaniasis in Bihar, India: a transmission-dynamics study.
    Singh OP; Tiwary P; Kushwaha AK; Singh SK; Singh DK; Lawyer P; Rowton E; Chaubey R; Singh AK; Rai TK; Fay MP; Chakravarty J; Sacks D; Sundar S
    Lancet Microbe; 2021 Jan; 2(1):e23-e31. PubMed ID: 33615281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India.
    Singh RP; Picado A; Alam S; Hasker E; Singh SP; Ostyn B; Chappuis F; Sundar S; Boelaert M
    Trop Med Int Health; 2012 Nov; 17(11):1345-8. PubMed ID: 22882665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visceral leishmaniasis with Roth spots.
    Meena J; Juneja M; Mishra D; Vats P; Pawaria A
    Oxf Med Case Reports; 2014 Sep; 2014(6):110-1. PubMed ID: 25988048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An In-depth Proteomic Map of Leishmania donovani Isolate from Post Kala-azar Dermal Leishmaniasis (PKDL) Patient.
    Routaray CB; Kumar A; Sundar S; Sathe G; Pawar H; Pai K
    Acta Parasitol; 2022 Jun; 67(2):687-696. PubMed ID: 35020128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kala-azar (visceral Leishmaniasis) from Khotang.
    Joshi S; Bajracharya BL; Baral MR
    Kathmandu Univ Med J (KUMJ); 2006; 4(2):232-4. PubMed ID: 18603904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visceral Leishmaniasis in a Non-endemic Region of Eritrea.
    Alamin AA
    Cureus; 2020 Nov; 12(11):e11318. PubMed ID: 33282593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visceral leishmaniasis without fever in an 11-month-old infant: a rare clinical feature of Kala-azar.
    Sayyahfar S; Ansari S; Mohebali M; Behnam B
    Korean J Parasitol; 2014 Apr; 52(2):189-91. PubMed ID: 24850963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematologic changes in visceral leishmaniasis/kala azar.
    Varma N; Naseem S
    Indian J Hematol Blood Transfus; 2010 Sep; 26(3):78-82. PubMed ID: 21886387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA polymorphism assay distinguishes isolates of Leishmania donovani that cause kala-azar from those that cause post-kala-azar dermal Leishmaniasis in humans.
    Sreenivas G; Raju BV; Singh R; Selvapandiyan A; Duncan R; Sarkar D; Nakhasi HL; Salotra P
    J Clin Microbiol; 2004 Apr; 42(4):1739-41. PubMed ID: 15071036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Para-kala-azar dermal leishmaniasis in a patient in Brazil: a case report.
    Lindoso JAL; Moreira CHV; Celeste BJ; Oyafuso LKM; Folegatti PM; Zijlstra EE
    Rev Soc Bras Med Trop; 2018; 51(1):105-107. PubMed ID: 29513829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L. (L.) chagasi in AIDS and visceral leishmaniasis (kala-azar) co-infection.
    Roselino AM; Chociay MF; Costa RS; Machado AA; Figueiredo JF
    Rev Inst Med Trop Sao Paulo; 2008; 50(4):251-4. PubMed ID: 18813767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Laboratory diagnosis of an imported case of visceral leishmaniasis in Henan Province].
    Su-Hua L; Li-Jun G; Ya-Lan Z; Rui-Min Z; Cheng-Yun Y; Dan Q; Ying L; De-Ling L; Yu-Ling Z; Hong-Wei Z; Bian-Li X
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2019 Jul; 31(4):456-459. PubMed ID: 31612690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of Post-Kala-azar Dermal Leishmaniasis.
    Ghosh P; Roy P; Chaudhuri SJ; Das NK
    Indian J Dermatol; 2021; 66(1):12-23. PubMed ID: 33911289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leishmanin and tuberculin sensitivity in leishmaniasis in the Sudan, with special reference to kala-azar.
    Zijlstra EE; el-Hassan AM
    Trans R Soc Trop Med Hyg; 1993; 87(4):425-7. PubMed ID: 8249072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human visceral leishmaniasis in kermanshah province, Western iran, during 2011-2012.
    Hamzavi Y; Hamzeh B; Mohebali M; Akhoundi B; Ajhang Kh; Khademi N; Ghadiri K; Bashiri H; Pajhouhan M
    Iran J Parasitol; 2012; 7(4):49-56. PubMed ID: 23323091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and Hematological Features of Visceral Leishmaniasis at Mymensingh Medical College Hospital.
    Malek MS; Robi IH; Islam MS; Kabir MA; Uddin MZ; Sumon SM; Siddiqui NI
    Mymensingh Med J; 2020 Oct; 29(4):879-886. PubMed ID: 33116091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.